Download PDF
Der Klinikarzt 2019; 48(07): 288-294
DOI: 10.1055/a-0969-1542
Schwerpunkt
© Georg Thieme Verlag Stuttgart · New York

Schwangerschaft bei chronisch-entzündlichen Darmerkrankungen

Interdisziplinäre Zusammenarbeit bei Diagnostik, Therapie und Prävention
Elke Roeb
1   Schwerpunkt Gastroenterologie, Medizinische Klinik II, Universitätsklinikum Gießen, Gießen
› Author Affiliations
Further Information

Publication History

Publication Date:
13 August 2019 (online)

Also available at
    Permissions and Reprints

ZUSAMMENFASSUNG

Die höchsten gemeldeten Prävalenzraten für die chronisch-entzündlichen Darmerkrankungen (CED) Morbus Crohn und Colitis ulcerosa liegen aktuell in Europa. Etwa die Hälfte der Patienten sind Frauen und die meisten davon sind im reproduktionsfähigen Alter. Die Betreuung von schwangeren Patientinnen mit CED ist eine Herausforderung für interdisziplinäre Behandlungsteams. Die Auswirkungen der CED und ihrer Therapien auf Schwangerschaft, Neugeborene und Stillzeit sowie die Auswirkungen einer Schwangerschaft auf die CED und die Gesundheit der Mütter werden häufig mit Angst und Sorge betrachtet. Oft wird die Therapie bei Schwangerschaft und Stillzeit abgebrochen, ein signifikantes Risiko für eine Verschlechterung der Krankheitsaktivität und somit das größte bekannte Risiko für Schwangerschaft und Geburt. Frauen und Schwangere mit CED optimal zu betreuen erfordert eine interdisziplinäre Zusammenarbeit bei Diagnostik, Therapie und Prävention.

 

  • Literatur

  • 1 Barmer GEK: https://www.barmer.de/blob/71456/1f5b78999d9b260f1b2a6ccbc4518170/data/die-chronisch-entzuendlichen-darmerkrankungen-morbus-crohn-und-colitis-ulcerosa.pdf abgerufen am 04.07.2019
    PubMed
  • 2 Ng SC, Shi HY, Hamidi N. et al Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2018; 390: 2769-2778
    PubMedGoogle Scholar
  • 3 Pinder M, Lummis K, Selinger CP. Managing inflammatory bowel disease in pregnancy: current perspectives. Clin Experiment Gastroenterol 2016; 9: 325-335
    CrossrefPubMedGoogle Scholar
  • 4 Cornish J, Tan E, Teare J. et al A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56: 830-837
    CrossrefPubMedGoogle Scholar
  • 5 Molnar T, Farkas K, Nagy F. et al Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study. Scand J Gastroenterol 2010; 45: 1302-1306
    CrossrefPubMedGoogle Scholar
  • 6 Nguyen GC, Seow CH, Maxwell C. et al The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150: 734-57 e1
    CrossrefPubMedGoogle Scholar
  • 7 Preiß JC, Bokemeyer B, Buhr HJ. et al Aktualisierte S3-Leitlinie – Morbus Crohn. Z Gastroenterol 2014; 52: 1431-1484
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Ng SC, Shi HY, Hamidi N. et al Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2018; 390: 2769-2778
    PubMedGoogle Scholar
  • 9 Pinder M, Lummis K, Selinger CP. Managing inflammatory bowel disease in pregnancy: current perspectives. Clin Experiment Gastroenterol 2016; 9: 325-335
    CrossrefPubMedGoogle Scholar
  • 10 Cornish J, Tan E, Teare J. et al A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56: 830-837
    CrossrefPubMedGoogle Scholar
  • 11 Centers for Disease Control and Prevention. U. S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Morb Mortal Wkly Rep 2010; 59: 1-88
    PubMedGoogle Scholar
  • 12 Santos MPC, Gomes C, Torres J. Familial and ethnic risk in inflammatory bowel disease. Ann Gastroenterol 2018; 31: 14-23
    PubMedGoogle Scholar
  • 13 Moller FT, Andersen V, Wohlfahrt J. et al Familial risk of inflammatory bowel disease: a population-based cohort study 1977–2011. Am J Gastroenterol 2015; 110: 564-571
    CrossrefPubMedGoogle Scholar
  • 14 Bennett RA, Rubin PH, Present DH. Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology 1991; 100: 1638-1643
    CrossrefPubMedGoogle Scholar
  • 15 Laharie D, Debeugny S, Peeters M. et al Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001; 120: 816-819
    CrossrefPubMedGoogle Scholar
  • 16 Cornish JA, Tan E, Teare J. et al The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum 2007; 50: 1128-1138
    CrossrefPubMedGoogle Scholar
  • 17 Rajaratnam SG, Eglington TW, Hider P. et al Impact of ileal pouch-anal anastomosis on female fertility: meta-analysis and systematic review. Int J Colorectal Dis 2011; 26: 1365-1374
    CrossrefPubMedGoogle Scholar
  • 18 Livingston D, Cohn D. Childlessness Up Among All Women. Down Among Women with Advanced Degrees.. Pew Research Center; Washington, DC: 2010
    Google Scholar
  • 19 Mahadevan U, McConnell RA, Chambers CD. Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel disease. Gastroenterology 2017; 152: 451-462 e2
    CrossrefPubMedGoogle Scholar
  • 20 Friedman S, Larsen PV, Fedder J. et al The reduced chance of a live birth in women with IBD receiving assisted reproduction is due to a failure to achieve a clinical pregnancy. Gut 2017; 66: 556-558
    PubMedGoogle Scholar
  • 21 Leung YP, Kaplan GG, Coward S. et al Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease. J Crohns Colitis 2015; 9: 223-230
    CrossrefPubMedGoogle Scholar
  • 22 Seow CH, Leung Y, Vande Casteele N. et al The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease. Aliment Pharmacol Ther 2017; 45: 1329-1338
    CrossrefPubMedGoogle Scholar
  • 23 Mahadevan U, Dubinsky MC, Su C. et al Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis. Inflamm Bowel Dis 2018; 24: 2494-2500
    CrossrefPubMedGoogle Scholar
  • 24 Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract 2012; 27: 136-137
    CrossrefPubMedGoogle Scholar
  • 25 Abhyankar A, Ham M, Moss AC. Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 460-466
    CrossrefPubMedGoogle Scholar
  • 26 Norgard B, Hundborg HH, Jacobsen BA. et al Disease activity in pregnant women with Crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 2007; 102: 1947-1954
    CrossrefPubMedGoogle Scholar
  • 27 Hatch Q, Champagne BJ, Maykel JA. et al Crohn’s disease and pregnancy: the impact of perianal disease on delivery methods and complications. Dis Colon Rectum 2014; 57: 174-178
    CrossrefPubMedGoogle Scholar
  • 28 Chaparro M, Verreth A, Lobaton T. et al Long-term safety of in utero exposure to anti-tnfα drugs for the treatment of inflammatory bowel disease: results from the Multicenter European TEDDY Study. Am J Gastroenterol 2018; 113: 396-403
    CrossrefPubMedGoogle Scholar
  • 29 Dignass A, Van Assche G, Lindsay JO. et al The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis 2010; 4: 28-62
    CrossrefPubMedGoogle Scholar
  • 30 Norgard B, Pedersen L, Christensen LA. et al Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007; 102: 1406-1413
    CrossrefPubMedGoogle Scholar
  • 31 Bandoli G, Palmsten K, Forbess Smith CJ. et al A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am 2017; 43: 489-502
    CrossrefPubMedGoogle Scholar
  • 32 Luu M, Benzenine E, Doret M. et al Continuous anti-Tnfα use throughout pregnancy: possible complications for the mother but not for the fetus. A retrospective cohort on the French National Health Insurance Database (EVASION). Am J Gastroenterol 2018; 113: 1669-1677
    CrossrefPubMedGoogle Scholar
  • 33 Remzi FH, Gorgun E, Bast J. et al Vaginal delivery after ileal pouch-anal anastomosis: a word of caution. Dis Colon Rectum 2005; 48: 1691-1699
    CrossrefPubMedGoogle Scholar
  • 34 Nguyen GC, Bernstein CN, Bitton A. et al Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology 2014; 146: 835-848 e6
    CrossrefPubMedGoogle Scholar
  • 35 Bates SM, Middeldorp S, Rodger M. et al Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis 2016; 41: 92-128
    CrossrefPubMedGoogle Scholar